The Multiple Sclerosis (MS) Rehabilitation & Wellness Research Center (MS RehabWell) is a group of clinician-scientists committed to investigating novel interventions to help people with MS live their best lives. We focus on innovative clinical research to improve the delivery and utilization of effective treatments for MS and comorbid conditions, including chronic pain, fatigue, and depression, to affect system-level changes to improve care for people living with MS. We believe in mentoring the next generation of leaders and providers in rehabilitation medicine through fellowship, trainings, and educational programs.
We prioritize patient-centered research that engages people affected by MS, including patients, families, clinicians, MS organizations, and healthcare stakeholders throughout the research process.
UW Medicine has been at the forefront of MS research for more over four decades. In 1984, Dr. George Kraft made a significant breakthrough by publishing one of the pioneering papers that established the crucial role of fatigue in MS. Since then, we have been consistently producing valuable research on various aspects of MS, including symptoms, functioning, and quality of life.
Our commitment to scientific excellence aimed at improving the lives of people with MS remains unwavering.
Our investigators have received funding from the National Institutes of Health; National Institute on Disability, Independent Living, and Rehabilitation Research; Patient-Centered Outcomes Research Institute; National Multiple Sclerosis Society; Consortium of Multiple Sclerosis Centers; industry sponsors; and private donations.
We are located in the UW Medicine’s Multiple Sclerosis Center and operate within the UW Medicine Department of Rehabilitation Medicine with affiliates across UW Medicine.
